News
SRDX
29.95
-0.03%
-0.01
Surmodics cuts workforce by 13% after FDA declines to approve drug-coated balloon
Seeking Alpha · 7h ago
BRIEF-Surmodics To Reduce Company's Workforce By Approximately 13%
Reuters · 8h ago
Earnings Outlook For Surmodics
Benzinga · 13h ago
Barrington Research Maintains Outperform on Surmodics, Lowers Price Target to $61
Benzinga · 01/20 14:11
--Barrington Adjusts Price Target on SurModics to $61 From $70, Maintains Outperform Rating
--Barrington Adjusts Price Target on SurModics to $61 From $70, Maintains Outperform Rating
MT Newswires · 01/20 09:39
Hot Stocks: CNCE jumps on takeover deal; SRDX plunges; RIVN sets new low; EDU reaches 52-week high
Seeking Alpha · 01/19 22:59
Dow Drops 150 Points; Crude Oil Up 1%
Benzinga · 01/19 19:54
Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga · 01/19 18:33
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 01/19 17:30
Nasdaq Down Over 100 Points; Procter & Gamble Posts In-Line Earnings
Benzinga · 01/19 17:00
Surmodics sinks as FDA declines to approve drug-coated balloon
Seeking Alpha · 01/19 16:36
Dow Falls 200 Points; Jobless Claims Drop To 4-Month Low
Benzinga · 01/19 15:13
NeuroSense, RenovoRx top healthcare gainers; Jupiter Wellness, Surmodics among losers
Seeking Alpha · 01/19 15:00
Surmodics Stock Slides Following Regulatory Setback For Its SurVeil Drug-Coated Balloon
Benzinga · 01/19 14:52
SurModics (SRDX) Gets a Buy from Needham
TipRanks · 01/19 13:55
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 01/19 13:06
BRIEF-Surmodics Provides Update Related To FDA Premarket Approval Application
Reuters · 01/19 12:48
Surmodics Provides Regulatory Update Related To Its FDA Premarket Approval Application For The SurVeil Drug-Coated Balloon
Benzinga · 01/19 12:01
SurModics Says FDA Letter Indicated SurVeil Drug-Coated Balloon Application Not Currently Approvable
SurModics Says FDA Letter Indicated SurVeil Drug-Coated Balloon Application Not Currently Approvable
MT Newswires · 01/19 08:08
Inotiv: High Expenses Likely To Impair Long-Term Profitability
Seeking Alpha · 01/16 14:10
More
Webull provides a variety of real-time SRDX stock news. You can receive the latest news about Surmodics Inc through multiple platforms. This information may help you make smarter investment decisions.
About SRDX
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The Company operates through two segments: Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment manufactures performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices, as well as drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that includes coronary, peripheral, neurovascular and structural heart, among others. The IVD segment designs, develops and manufactures component products and technologies for diagnostic immunoassay, as well as molecular tests and biomedical research applications, with products that include protein stabilizers, substrates, surface coatings and antigens.